TY - JOUR
T1 - Ultrashort Cell-Penetrating Peptides for Enhanced Sonophoresis-Mediated Transdermal Transport
AU - Schnaider, Lee
AU - Shimonov, Leah
AU - Kreiser, Topaz
AU - Zaguri, Dor
AU - Bychenko, Darya
AU - Brickner, Itzchak
AU - Kolusheva, Sofiya
AU - Lichtenstein, Alexandra
AU - Kost, Joseph
AU - Gazit, Ehud
N1 - Funding Information:
We thank Zohar Arnon for his valuable assistance in figure preparation and confocal microscopy and Yael Diesendruck and Prof. Itai Benhar’s group for their generosity in providing labeled streptavidin. We thank the members of the Gazit group for fruitful discussions. This project was partially supported by a scholarship administered by the Israeli Ministry of Science, Technology and Space and The Marian Gertner Institute for Medical Nanosystems (L.S.).
Publisher Copyright:
©
PY - 2020/12/21
Y1 - 2020/12/21
N2 - The skin is a key site for drug administration because of its large surface area and noninvasive accessibility. However, the dermal architecture serves as an excellent barrier, protecting from external mechanical, chemical, microbial, and physical perturbations. Most drugs display poor permeability through this barrier, thus making dermal and subdermal delivery challenging. Cell-penetrating peptides (CPPs), a diverse group of relatively short cationic and amphipathic membrane-interacting peptides, are fast becoming an important class of drug carriers and could potentially be developed for the dermal delivery of active molecules. However, the mechanism of CPP transdermal delivery is not fully understood, and there is a genuine need for a minimal model to understand this important phenomenon. Here, we demonstrate the potent membrane interactions of a minimal four-amino-acid-long CPP as well as the significance of guanidinium patterning and cationic nature of this palindromic peptide on its bioactivity. Furthermore, we demonstrate the biocompatibility of this peptide as well as its rapid cellular uptake and endosomal distribution. Finally, by utilizing a porcine full-thickness skin model, we demonstrate the substantial independent dermal and sonophoresis-based transdermal penetration of this minimal model. These results provide a minimal model for CPPs which can be easily manipulated for further biophysical and biochemical evaluations as well as a potent functional CPP with excellent skin permeability, which can be utilized for a wide variety of cosmetic and medical applications.
AB - The skin is a key site for drug administration because of its large surface area and noninvasive accessibility. However, the dermal architecture serves as an excellent barrier, protecting from external mechanical, chemical, microbial, and physical perturbations. Most drugs display poor permeability through this barrier, thus making dermal and subdermal delivery challenging. Cell-penetrating peptides (CPPs), a diverse group of relatively short cationic and amphipathic membrane-interacting peptides, are fast becoming an important class of drug carriers and could potentially be developed for the dermal delivery of active molecules. However, the mechanism of CPP transdermal delivery is not fully understood, and there is a genuine need for a minimal model to understand this important phenomenon. Here, we demonstrate the potent membrane interactions of a minimal four-amino-acid-long CPP as well as the significance of guanidinium patterning and cationic nature of this palindromic peptide on its bioactivity. Furthermore, we demonstrate the biocompatibility of this peptide as well as its rapid cellular uptake and endosomal distribution. Finally, by utilizing a porcine full-thickness skin model, we demonstrate the substantial independent dermal and sonophoresis-based transdermal penetration of this minimal model. These results provide a minimal model for CPPs which can be easily manipulated for further biophysical and biochemical evaluations as well as a potent functional CPP with excellent skin permeability, which can be utilized for a wide variety of cosmetic and medical applications.
KW - cell-penetrating peptides
KW - diphenylalanine
KW - membrane interactions
KW - sonophoresis
KW - transdermal delivery
UR - http://www.scopus.com/inward/record.url?scp=85097874298&partnerID=8YFLogxK
U2 - 10.1021/acsabm.0c00682
DO - 10.1021/acsabm.0c00682
M3 - Article
AN - SCOPUS:85097874298
SN - 2576-6422
VL - 3
SP - 8395
EP - 8401
JO - ACS Applied Bio Materials
JF - ACS Applied Bio Materials
IS - 12
ER -